Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Bitcoin Rises While Ethereum, Dogecoin Stay Flat Amid Stock Reversal; ASML Struggles, Nvidia and AMD Recover; Stellantis Recalls 21K Hybrid SUVs Over Brake Pedal Issue - Top Headlines Today While US Slept
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers AMD NVDA SPY
Hims & Hers Shares Have Rallied 22% This Week. Why That Move Is Now At Risk.
Via Investor's Business Daily
Exposures Product Safety
Tickers HIMS LLY NVO
Stellantis Recalls Nearly 21K Plug-In Hybrid SUVs In US Over Concerns Of Brake Pedal Disengaging
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers STLA
FDA Approves NovoCure's Portable Device Producing Tumor-Treating Electric Fields For Previously Treated Lung Cancer Patients
Via Benzinga
Exposures Product Safety
Tickers NVCR
Should Eli Lilly Investors Worry About This Unexpected FDA Move?
Via The Motley Fool
Exposures Product Safety
Tickers LLY
CCHR Wants Increased Consumer Awareness About "Prescriptions for Violence"
Via PRLog
Exposures Product Safety
Tickers EB
The Heart and Soul of Park Slope: Alan Davidoff
Via Get News
Topics Product Recall
Exposures Legal Product Safety
CCHR Protests Electric Shocking of Autistic Students
Via Press Release Distribution Service
Exposures Product Safety
Cher Wolf Design Group Announces Its "Hosting the Holidays!" Theme for 2024
Via PRLog
Topics Product Recall
Exposures Legal Product Safety
Researchers Report Concern over Antidepressants Causing Long-Lasting Sexual Dysfunction; CCHR Calls on FDA to Act
Via Press Release Distribution Service
Exposures Product Safety
Nano Hearing Aids' CEO Targets Key Global Markets With Ambitious Worldwide Tour
Via Press Release Distribution Service
Exposures Product Safety
Novocure Shoots Skyward, Reversing Setbacks, After FDA Approves Lung Cancer Treatment
Via Investor's Business Daily
Exposures Product Safety
Tickers BMY MRK NVCR
BioMedNewsBreaks — Annovis Bio Inc. (NYSE: ANVS) Receives FDA Clearance for Pivotal Phase 3 Alzheimer’s Trial, Launch Set for Early 2025
Via Investor Brand Network
Exposures Product Safety
Tickers ANVS
Baxter's North Carolina Plant Recovery Underway After Hurricane Flooding, Starts Product Imports
Via Benzinga
Exposures Product Safety
Tickers BAX
Las Vegas Eye Institute Clarifies Ideal Age for LASIK Surgery, Emphasizes Importance of Vision Stability
Via Press Advantage
Exposures Product Safety
Hims & Hers Health Pops After FDA Allows Compounded Copies Of Eli Lilly's Obesity Drug
Via Investor's Business Daily
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers HIMS LLY
InvestorNewsBreaks – Longeveron Inc. (NASDAQ: LGVN) to Present ‘Important’ Lomecel-B(TM) Data at the 17th Clinical Trials on Alzheimer’s Disease Conference
Via Investor Brand Network
Exposures Product Safety
Tickers LGVN
FDA To Reassess Ban On Cheaper, Compounded Versions of Eli Lilly Weight Loss Drugs
Via Benzinga
Exposures Product Safety
Tickers LLY
FDA Approves Pfizer's Second Hemophilia Drug With Six Months
Via Benzinga
Exposures Product Safety
Tickers PFE SGMO
Listeria Scare Prompts Albertsons To Recall Certain Ready-To-Eat Meals In Multiple States
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers ACI FXG
Where Does Hims & Hers Stock Go From Here?
Via The Motley Fool
Exposures Product Safety
Tickers CVS HIMS WBA
Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health
Via Newsfile
Exposures Product Safety
Tickers ELTP
Introducing Garrett Shultz’s New Single: “You Over Me”
Via AB Newswire
Topics Product Recall
Exposures Legal Product Safety
Eli Lilly Issues Cease-And-Desist Letters to Compounders Over Weight-Loss Drug Copies As Shortage Resolves
Via Benzinga
Exposures Product Safety
Tickers LLY NVO
The Future of Medical Devices: Two Strong Buys You Can't Miss
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence Product Safety
Tickers INFU TCMD
BioMedNewsBreaks — Oragenics, Inc. (NYSE American: OGEN) Reports on Lead Candidate Drug Development, ‘Urgency’ to Advance First-in-Class Concussion Treatment
Via Investor Brand Network
Exposures Product Safety
Tickers OGEN
Travere Therapeutics Hits 14-Month High On A Promising FDA 'Pivot' In Kidney Disease
Via Investor's Business Daily
Exposures Product Safety
Tickers TVTX
What's Going With WeightWatchers Stock On Wednesday?
Via Benzinga
Exposures Product Safety
Tickers LLY NVO WW
Honda Recalls 1.7M Vehicles Over Steering Gearbox Defect
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers HAIL HMC
Why Soleno Therapeutics Stock Blasted 9% Higher Today
Via The Motley Fool
Exposures Product Safety
Tickers SLNO
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.